Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 176-183

  Schmidt, S L ^a   Nambiar, A M ^a   Tayob, N ^b   Sundaram, B ^a   Han, M K ^a   Gross, B H ^a   Kazerooni, E A ^a   Chughtai, A R ^a   Lagstein, A ^a   Myers, J L ^a   Murray, S ^b   Toews, G B ^a   Martinez, F J ^a   Flaherty, K R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis; Prognosis; Pulmonary function; Survival

Indexed keywords

ACCURACY; ADULT; ARTICLE; COHORT ANALYSIS; COMPOSITE PHYSIOLOGIC INDEX; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL;

AGED; CARBON MONOXIDE; DIFFUSION; EMPHYSEMA; FEMALE; FIBROSIS; FORCED EXPIRATORY VOLUME; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY FIBROSIS; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 79960193484     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00114010     Document Type: Article

References (27)

1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142: 963-967.
3. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
4. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19: 275-283. (Pubitemid 34162828)
5. Collard HR, King TE Jr. Demystifying idiopathic interstitial pneumonia. Arch Intern Med 2003; 163: 17-29. (Pubitemid 36091597)
6. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454. (Pubitemid 24068994)
7. Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 543-548. (Pubitemid 37088596)
8. Collard H, King T, Bartelson B, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 538-542. (Pubitemid 37088595)
9. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and sixminute- walk test. Am J Respir Crit Care Med 2006; 174: 803-809. (Pubitemid 44511662)
10. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537. (Pubitemid 37088594)
11. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-1090. (Pubitemid 37338937)
12. Fell CD, Liu LX, Motika C, et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 402-407.
13. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242-248. (Pubitemid 27053171)
14. Ryu JH, Colby TV, Hartman TE, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001; 17: 122-132. (Pubitemid 32605656)
15. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006; 3: 293-298.
16. Schwartz DA, Merchant RK, Helmers RA, et al. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144: 504-506.
17. Flaherty KR, Brown K, Colby TV, et al. Smoking related interstitial lung disease - an international working group report. Eur Respir J 2006; 28: Suppl. 50, 382s.
18. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: 962-969. (Pubitemid 36408161)
19. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387. (Pubitemid 26072233)
20. Cox D. Regression models and life tables (with discussion). J R Stat Soc 1972; B34: 187-220.
21. Schmidt SL, Sundaram B, Tayob N, et al. Longitudinal changes in the composite physiologic index and pulmonary function in patients with idiopathic pulmonary fibrosis and emphysema. Am J Respir Crit Care Med 2010; 181: A1122.
22. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
23. Behr J, Demedts M, Buhl R, et al. Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial. Respir Res 2009; 10: 101.
24. King T, Safrin S, Starko K, et al. Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. Chest 2005; 127: 171-177. (Pubitemid 41724573)
25. Kitaguchi Y, Fujimoto K, Hanaoka M, et al. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15: 265-271.
26. Cottin V, Nunes H, Brillet P-Y, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-593. (Pubitemid 41448654)
27. Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105-111.